MedTrace Logo

Endovascular Aortic Repair for Aortic Dissection

NCT01505309 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2016-01-01

No results posted yet for this study

Summary

The purpose of this study is to investigate the short to mid term efficacy and safety of Thoracic Endovascular Aortic Repair (TEVAR) in patients who had aortic lesions, such as descending aortic/arch aneurysm, pseudo-aneurysm, Stanford Type B dissection, dissection with primary tear located in the aortic arch, et al.

Conditions

  • Aorta Dissection
  • Aorta Aneurysm

Interventions

DEVICE

Stent Graft (Medtronic, Microport, Ankura)

Medtronic Stent Graft（Medtronic Medtronic, Inc., US） Microport Stent Graft（Microport Co.,LTD.，Shanghai, China） Ankura Stent Graft（Lifetech Scientific Co.,LTD.，Shenzhen, China）

Sponsors & Collaborators

  • Changhai Hospital

    collaborator OTHER

  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Jian Yang, M.D., Ph.D · Department of Cardiovascular Surgery of Xijing Hospital, Fourth Military Medical University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2016-12-31
Completion
2018-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01505309 on ClinicalTrials.gov